Nxera Pharma Co., Ltd.
4565ネクセラファーマ株式会社
Latest half-year results
First half · fiscal year to 2026-12 · filed 2026-08-07For the first half of the fiscal year to 2026-12: Revenue ¥18.9 billion (+25.3% YoY), Profit before tax ¥1.4 billion, Net income ¥1.6 billion.
| This period | Year on year | |
|---|---|---|
| Revenue | ¥18.9bn | +25.3% |
| Profit before tax | ¥1.4bn | — |
| Net profit to owners | ¥1.6bn | — |
From the securities report on EDINET, which states no forecast. History via /v1/companies/4565/earnings-releases.
Financials
IFRS · consolidated · fiscal year to 2025-12-31- Revenue
- ¥29.6bn
- Net income
- −¥12.5bn
- ROE
- -19.3%
- Equity ratio
- 45.3%
- Dividend / share
- —
- Employees
- 382
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | ¥29.6bn | −¥12.5bn | ¥134.8bn | ¥61.0bn | -19.3% | ¥-138.8 | −¥2.7bn |
| 2024-12-31 | ¥28.8bn | −¥4.8bn | ¥151.5bn | ¥68.5bn | -7.2% | ¥-53.92 | −¥7.7bn |
| 2023-12-31 | ¥12.8bn | −¥7.2bn | ¥157.2bn | ¥66.8bn | -11.5% | ¥-87.18 | −¥5.3bn |
| 2022-12-31 | ¥15.6bn | ¥0.4bn | ¥99.4bn | ¥57.9bn | 0.7% | ¥4.68 | ¥10.0bn |
| 2021-12-31 | ¥17.7bn | ¥1.0bn | ¥97.0bn | ¥57.5bn | 1.9% | ¥12.53 | ¥7.1bn |
Indicators
Computed by us from filings · fiscal year to 2025-12-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | -19.3 | 2.7 |
| Ordinary margin | -0.5048 | 1.6 |
| Equity ratio, % | 45.3 | 34.7 |
| Revenue growth | 0.0271 | 37.5 |
| Net income growth | -1.5899 | 5.3 |
| Operating cash flow / assets | -0.0198 | 12 |
Results wording balance: +0.33. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥53.0bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥265m. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/4565/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/4565/votingOwnership changes
All companies →- 2026-09-25
Goldman Sachs Japan Co.,Ltd. cut holdings in Nxera Pharma Co., Ltd. (4565) to 3.30% from 5.11%, below the 5% threshold.
- 2026-09-07
Goldman Sachs Japan Co.,Ltd. disclosed a 5.11% stake in Nxera Pharma Co., Ltd. (4565), crossing the 5% reporting threshold.
- 2026-08-21
Mizuho Securities Co., Ltd. raised holdings in Nxera Pharma Co., Ltd. (4565) to 6.62% from 5.60%.
- 2026-05-22
Mizuho Securities Co., Ltd. raised holdings in Nxera Pharma Co., Ltd. (4565) to 5.60% from 5.53%.
- 2026-05-12
Mizuho Securities Co., Ltd. disclosed a 5.53% stake in Nxera Pharma Co., Ltd. (4565), crossing the 5% reporting threshold.
- 2026-04-30
individual filer raised holdings in Nxera Pharma Co., Ltd. (4565) to 11.67% from 10.64%.
- 2026-04-22
Mizuho Securities Co., Ltd. cut holdings in Nxera Pharma Co., Ltd. (4565) to 4.35% from 5.37%, below the 5% threshold.
- 2026-01-22
Mizuho Securities Co., Ltd. reduced holdings in Nxera Pharma Co., Ltd. (4565) to 5.37% from 5.45%.
- 2025-12-04
individual filer raised holdings in Nxera Pharma Co., Ltd. (4565) to 10.64% from 9.50%.
- 2025-12-04
Holdings of individual filer in Nxera Pharma Co., Ltd. (4565) moved above 10% (9.50% -> 10.64%).
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| individual filer | 2022-04-20 – 2026-04-23 | +685,000 | +0.77pt | — | — |
| Taiyo Pacific Partners L.P. | 2022-12-08 – 2025-06-18 | -2,719,600 | −3.13pt | ¥1,004 | ¥1,004–1,004 |
| JICベンチャー・グロース・インベストメンツ株式会社 | 2023-12-15 – 2023-12-15 | +5,610,000 | +6.27pt | ¥1,426 | ¥1,426–1,426 |
| Taiyo Pacific CG LLC | 2021-11-10 – 2021-12-23 | +43,500 | +0.05pt | — | — |
| Taiyo Fund Management LLC | 2021-11-15 – 2021-12-23 | +63,100 | +0.07pt | — | — |
| individual filer | 2021-11-15 – 2021-12-23 | -184,600 | −0.23pt | — | — |
| Taiyo Pacific Partners L.P. | 2021-12-23 – 2021-12-23 | 0 | 0.00pt | — | — |
| Taiyo Fund, L.P. | 2021-12-23 – 2021-12-23 | 0 | 0.00pt | — | — |
| Capital International Inc. | 2021-06-07 – 2021-08-13 | -6,500 | +0.01pt | — | — |
| Capital International Sarl | 2021-07-27 – 2021-08-13 | -52,300 | −0.06pt | — | — |
| Capital International Limited | 2021-08-04 – 2021-08-13 | -11,000 | 0.00pt | — | — |
| キャピタル・インターナショナル株式会社 | 2021-06-24 – 2021-08-13 | -723,800 | −0.87pt | — | — |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4565/trades.
5% filings
Large shareholding reports on 4565| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-09-25 | Goldman Sachs Japan Co.,Ltd. | 3.30% | −1.81pt | — |
| 2026-09-07 | Goldman Sachs Japan Co.,Ltd. | 5.11% | — | — |
| 2026-08-21 | Mizuho Securities Co., Ltd. | 6.62% | +1.02pt | — |
| 2026-05-22 | Mizuho Securities Co., Ltd. | 5.60% | +0.07pt | — |
| 2026-05-12 | Mizuho Securities Co., Ltd. | 5.53% | — | — |
| 2026-04-30 | individual filer | 11.67% | +1.03pt | pure investment |
| 2026-04-22 | Mizuho Securities Co., Ltd. | 4.35% | −1.02pt | — |
| 2026-01-22 | Mizuho Securities Co., Ltd. | 5.37% | −0.08pt | — |
| 2025-12-04 | individual filer | 10.64% | +1.14pt | pure investment |
| 2025-06-25 | Taiyo Pacific Partners L.P. | 4.80% | −1.06pt | may make proposals pure investment |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- — issues
- Book value
- —
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 0
| Holds | Book value | Shares vs. prior year | Mutual |
|---|---|---|---|
| Centassa Pharmaceuticals PLC | ¥1,775m | -51.2% | no |
Purposes, all holdings and mutual flags via /v1/companies/4565/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2025-12-31| Shareholder | Shares | Ratio |
|---|---|---|
| 日本マスタートラスト信託銀行株式会社(信託口) | 8,533,800 | 9.43% |
| individual holder | 7,270,000 | 8.03% |
| JICVGIオポチュニティファンド１号投資事業有限責任組合 | 5,610,000 | 6.20% |
| individual holder | 3,052,912 | 3.37% |
| BROWN BROTHERS HARRIMAN(LUXEMBOURG) SCA CUSTODIANFOR ARCUS FUND SICAV - ARCUS JAPAN FUND | 2,542,800 | 2.81% |
| ファイザー株式会社 | 1,885,136 | 2.08% |
| 株式会社SBI証券 | 1,537,549 | 1.70% |
| MSIP CLIENT SECURITIES | 1,358,300 | 1.50% |
| BOFAS INC OMNIBUS ACCOUNT | 1,212,800 | 1.34% |
| individual holder | 1,079,956 | 1.19% |
U.S. funds holding 4565
SEC Form N-PORT, reports to 2026-07-3137 U.S. funds held 5,552,906 shares worth $31.2m.
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 1,060,900 | $5.8m | 0.001% | 2026-07-31 |
| VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS | 693,000 | $4.2m | 0.001% | 2026-06-30 |
| iShares Core MSCI EAFE ETF iShares Trust | 612,100 | $3.4m | 0.002% | 2026-07-31 |
| THE JAPANESE SMALL COMPANY SERIES DFA INVESTMENT TRUST CO | 374,500 | $2.1m | 0.051% | 2026-07-31 |
| Dimensional International Small Cap ETF Dimensional ETF Trust | 320,500 | $1.8m | 0.031% | 2026-07-31 |
Up to 25 funds per stock via the API.
Get this as JSON
GET /v1/companies/4565
GET /v1/companies/4565/financials
GET /v1/companies/4565/details
GET /v1/companies/4565/segments
GET /v1/companies/4565/voting
GET /v1/companies/4565/tender-offers
GET /v1/companies/4565/indicators
GET /v1/companies/4565/earnings-releases
GET /v1/events?ticker=4565
GET /v1/companies/4565/trades
GET /v1/companies/4565/cross-holdings
GET /v1/companies/4565/brief